Skip to content

Internet-based Behavioral Pain Management

Development of an Internet-based Behavioral Pain Management Intervention

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01918189
Enrollment
59
Registered
2013-08-07
Start date
2014-07-01
Completion date
2018-12-31
Last updated
2019-11-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Low Back Pain

Keywords

back pain, low back pain, chronic pain, cognitive behavior therapy, behavior therapy

Brief summary

The purpose of the proposed project is to develop and test how well an internet-based behavioral pain self-management program, the Pain EASE program, can be used for treating low back pain in Veterans. Veterans' experiences with usability and satisfaction with the Pain EASE program will also be examined. Behavioral interventions such as exercise and cognitive behavior therapy are known to be effective for low back pain but are often not readily available or easily accessed. Veterans will be able to access the Pain EASE program via their computer with an internet connection, which will increase access to this type of treatment. Study participants will receive 10 weeks of access to the Pain EASE program, which will teach them pain coping skills to manage their low back pain. The primary outcome is pain-related functional interference.

Detailed description

OBJECTIVES: The primary objectives of the proposed study are to: (1) develop an integrative, Internet-based, Veteran-centered behavioral intervention, the Pain EASE program for chronic low back pain (CLBP), and (2) examine preliminary efficacy, usability, and satisfaction of this intervention in a representative sample of Veterans with CLBP. The primary hypothesis states that a clinically meaningful reduction in pain-related functional interference will be observed following ten weeks of exposure to the Pain EASE program relative to baseline. The secondary hypotheses state that clinically meaningful reductions in ratings of average pain intensity on a 0 (no pain) to 10 (worst pain imaginable) numeric rating scale at the ten week post-baseline follow-up assessment interval will be observed, in addition to statistically significant reductions in fatigue, sleep problems, depressive symptoms, and negative mood at the ten week post-baseline assessment. The tertiary hypotheses state that participants will report high levels of interest, site usage, and satisfaction. RESEARCH DESIGN: A non-randomized pilot study with two phases is proposed to develop and evaluate an internet-based behavioral pain self-management program. Phase I will solely involve qualitative data collection. Repeated quantitative assessments during Phase II will be conducted at baseline and 10-weeks post-baseline. METHODOLOGY: A 24-month pilot study with two phases is proposed. During Phase I, the Pain EASE program will be developed and feedback from 15 Veterans with CLBP and an Expert Panel of pain management clinicians will be used to modify the program. During Phase II, a pilot feasibility trial of the Pain EASE program with 55 Veterans with CLBP will be conducted. Subjects will be a total of 70 patients receiving care at the VA Connecticut Healthcare System (VACHS) who report chronic low back pain. The primary criteria for inclusion are constant pain of at least three months duration with at least a moderate level of average pain (i.e., scores of 4 or greater on a 0 \[no pain\] to 10 \[worst pain imaginable\]) on a numerical rating scale of pain and indication of the preparation, action, or maintenance stage of readiness to change on a brief five item staging checklist. All patients must have access to a computer with an internet connection. Excluded will be patients with life threatening or acute physical illness, current alcohol or substance abuse or dependence, current psychosis, suicidal ideation, dementia, and individuals seeking surgical pain treatment. All participants will continue to receive their usual care from Veterans Health Administration (VHA) providers. During the 10-week therapeutic window, weekly telephone calls from research staff will serve to cue and monitor participants' use of the Internet program. At ten weeks post-baseline, participants will be formally reassessed. Primary and secondary hypotheses involving quantitative data will be analyzed using an intent-to-treat principle and will employ t-tests and non-parametric analogs and regression analyses.

Interventions

BEHAVIORALbehavioral pain self-management intervention Pain EASE

10 modules describing behavioral and cognitive pain coping skills such as relaxation and stress reduction methods, exercise and structured physical activity, and activity pacing

Sponsors

VA Office of Research and Development
Lead SponsorFED

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Presence of at least a moderate level of chronic low back pain (i.e., numeric rating scale pain scores of 4) and presence of low back pain for a period of 3 months; * Availability of a computer with Internet access; * Indication of the preparation, action, or maintenance stage of readiness to change on a brief five item staging checklist and a rating of at least 4 or greater on a 0 (not at all interested) to 10 (extremely interested) rating scale designed to ensure participants' interest in receiving pain self-management via the Internet; * Veteran receiving care at VA Connecticut Healthcare System

Exclusion criteria

* life threatening or acute medical condition that could impair participation (e.g., severe COPD, lower limb amputation, terminal cancer); * psychiatric condition (e.g., active substance abuse, psychosis or suicidality) that could impair participation * surgical interventions for pain during their participation in this study * sensory deficits that would impair participation (e.g., visual impairment affecting ability to navigate Internet-based intervention).

Design outcomes

Primary

MeasureTime frameDescription
Multidimensional Pain Inventory Interference Subscalebaseline and 10 weeks post-baselineSelf-report measure of pain-related functional interference. The 9-item Interference subscale, scores ranging from 0-6, of the West Haven-Yale Multidimensional Pain Inventory (WHYMPI)-Interference scale assesses pain-related interference. Lower scores indicate less pain-related interference (i.e., better outcome). A reduction in WHYMPI-Interference Scale scores of 0.6 or greater has been identified as an indicator of meaningful improvement in physical functioning. Outcome was calculated as a change from baseline score to 10-week post-baseline score (i.e., 10 weeks post-baseline value minus baseline value).

Secondary

MeasureTime frameDescription
Numeric Rating Scale of Pain Intensitybaseline and 10 weeks post-baselineself-report measure of pain intensity measured on a 0-10 likert scale. Participants are asked, Please rate your pain by indicating the number that best describes your average pain over the past week on a 0 (no pain) to 10 (pain as bad as you can imagine) scale. Scores of 1-3 reflect mild pain, 4-6 moderate pain, and 7-10 severe pain. Lower scores reflect less pain, and therefore, better outcome. Outcome was calculated as a change from baseline score to 10-week post-baseline score (i.e., 10 weeks post-baseline value minus baseline value).
Profile of Mood Statesbaseline and 10 weeks post-baselineTotal mood symptoms score reported. The 65-item Profile of Mood States (POMS) is a multidimensional measure of emotional functioning designed to assess six dimensions of mood over the past week, including today. Each item is scored on a 0-5 Likert scale, where 0= not at all and 5= extremely. Total Mood Disturbance score ranges from 0 to 200. Higher scores reflect poorer functioning. Lower scores correspond to better outcomes. Outcome was calculated as a change from baseline score to 10-week post-baseline score (i.e., 10 weeks post-baseline value minus baseline value).
Multidimensional Fatigue Inventorybaseline and 10 weeks post-baselineGeneral fatigue scale reported. Fatigue was assessed using the Multidimensional Fatigue Inventory (MFI), which is a 20 item measure that can be scored to produce 5 dimensions: general fatigue, physical fatigue, mental fatigue, reduced motivation, and how subscale statements regarding fatigue represent their experiences. Score range from 4 to 20. Higher total scores correspond with more acute levels of fatigue. Lower scores correspond to better outcomes. Outcome was calculated as a change from baseline score to 10-week post-baseline score (i.e., 10 weeks post-baseline value minus baseline value).
Medical Outcomes Study Sleep Scalebaseline and 10 weeks post-baselineThe MOS Sleep Scale is a 12 item measure that is segregated into subscales addressing seven sleep domains (i.e. sleep disturbance, snoring, awaken short of breath or with headache, adequacy of sleep, somnolence, a problems index 1 and a problems index 2). An additional single item assesses quantity of sleep. The sleep domains and problems index are scored on a 0 - 100 possible range, and higher scores indicate more of the concept being measured. Lower scores on sleep disturbance, for example, reflect less disturbed sleep, which is a better outcome. Outcome was calculated as a change from baseline score to 10-week post-baseline score (i.e., 10 weeks post-baseline value minus baseline value).
Beck Depression Inventorybaseline and 10 weeks post-baselineDepressive symptom severity was assessed using the 21-item Beck Depression Inventory. Scores range from 0 - 63. Higher scores indicate more severe depression symptomatology. Lower scores correspond to better outcomes (i.e., less depressive symptom severity). Outcome was calculated as a change from baseline score to 10-week post-baseline score (i.e., 10 weeks post-baseline value minus baseline value).

Countries

United States

Participant flow

Recruitment details

Participant enrollment began July 1, 2014 and last data collection for primary outcome was October 31, 2018. Recruitment target of 58 participants was met. 59 participants enrolled in the study (i.e., signed informed consent) but 58 completed baseline measures and were included in outcomes analyses.

Participants by arm

ArmCount
10 Week Pain EASE Access
behavioral pain self-management intervention (Pain EASE) delivered via the Internet behavioral pain self-management intervention Pain EASE: 10 modules describing behavioral and cognitive pain coping skills such as relaxation and stress reduction methods, exercise and structured physical activity, and activity pacing
58
Total58

Baseline characteristics

Characteristic10 Week Pain EASE Access
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
12 Participants
Age, Categorical
Between 18 and 65 years
46 Participants
Age, Continuous55 years
STANDARD_DEVIATION 12
Beck Depression Inventory15.47 units on a scale
STANDARD_DEVIATION 1.37
Ethnicity (NIH/OMB)
Hispanic or Latino
1 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
54 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
3 Participants
Medical Outcomes Study Sleep Scale50.09 units on a scale
STANDARD_DEVIATION 3.8
Multidimensional Fatigue Inventory14.05 units on a scale
STANDARD_DEVIATION 0.52
Multidimensional Pain Inventory Interference Subscale3.82 units on a scale
STANDARD_DEVIATION 0.19
Pain Intensity Numeric Rating Scale5.91 units on a scale
STANDARD_DEVIATION 0.25
Profile of Mood States49.53 units on a scale
STANDARD_DEVIATION 5.62
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
0 Participants
Race (NIH/OMB)
Black or African American
19 Participants
Race (NIH/OMB)
More than one race
1 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
3 Participants
Race (NIH/OMB)
White
35 Participants
Region of Enrollment
United States
58 Participants
Sex: Female, Male
Female
4 Participants
Sex: Female, Male
Male
54 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 58
other
Total, other adverse events
0 / 58
serious
Total, serious adverse events
1 / 58

Outcome results

Primary

Multidimensional Pain Inventory Interference Subscale

Self-report measure of pain-related functional interference. The 9-item Interference subscale, scores ranging from 0-6, of the West Haven-Yale Multidimensional Pain Inventory (WHYMPI)-Interference scale assesses pain-related interference. Lower scores indicate less pain-related interference (i.e., better outcome). A reduction in WHYMPI-Interference Scale scores of 0.6 or greater has been identified as an indicator of meaningful improvement in physical functioning. Outcome was calculated as a change from baseline score to 10-week post-baseline score (i.e., 10 weeks post-baseline value minus baseline value).

Time frame: baseline and 10 weeks post-baseline

Population: 17 of the 58 participants who completed baseline did not complete 10-week post-baseline assessment (study endpoint)

ArmMeasureValue (LEAST_SQUARES_MEAN)
10 Week Pain EASE AccessMultidimensional Pain Inventory Interference Subscale0.53 score on a scale
p-value: 0.008Regression, Logistic
Secondary

Beck Depression Inventory

Depressive symptom severity was assessed using the 21-item Beck Depression Inventory. Scores range from 0 - 63. Higher scores indicate more severe depression symptomatology. Lower scores correspond to better outcomes (i.e., less depressive symptom severity). Outcome was calculated as a change from baseline score to 10-week post-baseline score (i.e., 10 weeks post-baseline value minus baseline value).

Time frame: baseline and 10 weeks post-baseline

ArmMeasureValue (LEAST_SQUARES_MEAN)
10 Week Pain EASE AccessBeck Depression Inventory-2.31 score on a scale
p-value: 0.03Regression, Logistic
Secondary

Medical Outcomes Study Sleep Scale

The MOS Sleep Scale is a 12 item measure that is segregated into subscales addressing seven sleep domains (i.e. sleep disturbance, snoring, awaken short of breath or with headache, adequacy of sleep, somnolence, a problems index 1 and a problems index 2). An additional single item assesses quantity of sleep. The sleep domains and problems index are scored on a 0 - 100 possible range, and higher scores indicate more of the concept being measured. Lower scores on sleep disturbance, for example, reflect less disturbed sleep, which is a better outcome. Outcome was calculated as a change from baseline score to 10-week post-baseline score (i.e., 10 weeks post-baseline value minus baseline value).

Time frame: baseline and 10 weeks post-baseline

ArmMeasureValue (LEAST_SQUARES_MEAN)
10 Week Pain EASE AccessMedical Outcomes Study Sleep Scale-4.95 score on a scale
p-value: 0.18Regression, Logistic
Secondary

Multidimensional Fatigue Inventory

General fatigue scale reported. Fatigue was assessed using the Multidimensional Fatigue Inventory (MFI), which is a 20 item measure that can be scored to produce 5 dimensions: general fatigue, physical fatigue, mental fatigue, reduced motivation, and how subscale statements regarding fatigue represent their experiences. Score range from 4 to 20. Higher total scores correspond with more acute levels of fatigue. Lower scores correspond to better outcomes. Outcome was calculated as a change from baseline score to 10-week post-baseline score (i.e., 10 weeks post-baseline value minus baseline value).

Time frame: baseline and 10 weeks post-baseline

ArmMeasureValue (LEAST_SQUARES_MEAN)
10 Week Pain EASE AccessMultidimensional Fatigue Inventory-0.3 score on a scale
p-value: 0.48Regression, Logistic
Secondary

Numeric Rating Scale of Pain Intensity

self-report measure of pain intensity measured on a 0-10 likert scale. Participants are asked, Please rate your pain by indicating the number that best describes your average pain over the past week on a 0 (no pain) to 10 (pain as bad as you can imagine) scale. Scores of 1-3 reflect mild pain, 4-6 moderate pain, and 7-10 severe pain. Lower scores reflect less pain, and therefore, better outcome. Outcome was calculated as a change from baseline score to 10-week post-baseline score (i.e., 10 weeks post-baseline value minus baseline value).

Time frame: baseline and 10 weeks post-baseline

ArmMeasureValue (LEAST_SQUARES_MEAN)
10 Week Pain EASE AccessNumeric Rating Scale of Pain Intensity-0.24 units on a scale
p-value: 0.27Regression, Logistic
Secondary

Profile of Mood States

Total mood symptoms score reported. The 65-item Profile of Mood States (POMS) is a multidimensional measure of emotional functioning designed to assess six dimensions of mood over the past week, including today. Each item is scored on a 0-5 Likert scale, where 0= not at all and 5= extremely. Total Mood Disturbance score ranges from 0 to 200. Higher scores reflect poorer functioning. Lower scores correspond to better outcomes. Outcome was calculated as a change from baseline score to 10-week post-baseline score (i.e., 10 weeks post-baseline value minus baseline value).

Time frame: baseline and 10 weeks post-baseline

ArmMeasureValue (LEAST_SQUARES_MEAN)
10 Week Pain EASE AccessProfile of Mood States-9.57 score on a scale
p-value: 0.02Regression, Logistic

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026